Literature DB >> 11162584

Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta.

P Wei1, Y G Zhao, L Zhuang, S Ruben, Q X Sang.   

Abstract

The adamalysins are involved in proteolysis, adhesion, fusion, and intracellular signaling. Human ADAM19/adamalysin-19 (A disintegrin and metalloproteinase 19) was identified from primary dendritic cell cDNA libraries. It has a signal sequence, a pro-domain with a "cysteine-switch" residue, a metalloproteinase domain with a zinc-binding site, a disintegrin, a cysteine-rich domain, an epidermal-growth-factor-like domain, a transmembrane domain, and a cytoplasmic domain with putative SH3 ligand binding sites. Its mRNA was expressed in the placenta, heart, bladder, lymph nodes, and leukocytes, colorectal adenocarcinoma SW 480, and other organs/cells. The hADAM19 recombinant protein was expressed in human cells. It formed a complex with and cleaved alpha-2 macroglobulin (alpha2-M). Its proteolytic activity was blocked by 1,10-phenanthroline, EDTA, EGTA, and a synthetic matrix metalloproteinase (MMP) inhibitor and not by the tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2. It did not cleave the MMP substrates tested, e.g., type I collagen and gelatin, casein, and four peptide substrates. Thus, hADAM19 is an active metalloproteinase and may have a specific substrate profile. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162584     DOI: 10.1006/bbrc.2000.4200

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Screen and identification of proteins interacting with ADAM19 cytoplasmic tail.

Authors:  Li Huang; Libing Feng; Limin Yang; Weiguo Zhou; Shouyuan Zhao; Changben Li
Journal:  Mol Biol Rep       Date:  2002-09       Impact factor: 2.316

2.  Day/night rhythms in gene expression of the normal murine heart.

Authors:  Tami Martino; Sara Arab; Marty Straume; Denise D Belsham; Nazneen Tata; Fang Cai; Peter Liu; Maria Trivieri; Martin Ralph; Michael J Sole
Journal:  J Mol Med (Berl)       Date:  2004-02-24       Impact factor: 4.599

3.  ADAM19 and HTR4 variants and pulmonary function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.

Authors:  Stephanie J London; Wei Gao; Sina A Gharib; Dana B Hancock; Jemma B Wilk; John S House; Richard A Gibbs; Donna M Muzny; Thomas Lumley; Nora Franceschini; Kari E North; Bruce M Psaty; Christie L Kovar; Josef Coresh; Yanhua Zhou; Susan R Heckbert; Jennifer A Brody; Alanna C Morrison; Josée Dupuis
Journal:  Circ Cardiovasc Genet       Date:  2014-06

4.  Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.

Authors:  Meng-Huee Lee; Vandana Verma; Klaus Maskos; Deepa Nath; Vera Knäuper; Philippa Dodds; Augustin Amour; Gillian Murphy
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

5.  Essential role for ADAM19 in cardiovascular morphogenesis.

Authors:  Hong-Ming Zhou; Gisela Weskamp; Valérie Chesneau; Umut Sahin; Andrea Vortkamp; Keisuke Horiuchi; Riccardo Chiusaroli; Rebecca Hahn; David Wilkes; Peter Fisher; Roland Baron; Katia Manova; Craig T Basson; Barbara Hempstead; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

6.  A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease.

Authors:  Matthew Moll; Victoria E Jackson; Bing Yu; Megan L Grove; Stephanie J London; Sina A Gharib; Traci M Bartz; Colleen M Sitlani; Josée Dupuis; George T O'Connor; Hanfei Xu; Patricia A Cassano; Bonnie Kaufmann Patchen; Woo Jin Kim; Jinkyeong Park; Kun Hee Kim; Buhm Han; R Graham Barr; Ani Manichaikul; Jennifer N Nguyen; Stephen S Rich; Lies Lahousse; Natalie Terzikhan; Guy Brusselle; Phuwanat Sakornsakolpat; Jiangyuan Liu; Christopher J Benway; Ian P Hall; Martin D Tobin; Louise V Wain; Edwin K Silverman; Michael H Cho; Brian D Hobbs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-28       Impact factor: 6.011

Review 7.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

8.  Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.

Authors:  Shiva Kalantari; Dorothea Rutishauser; Shiva Samavat; Mohsen Nafar; Leyla Mahmudieh; Mostafa Rezaei-Tavirani; Roman A Zubarev
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

9.  Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.

Authors:  Gerard Hoyne; Caroline Rudnicka; Qing-Xiang Sang; Mark Roycik; Sarah Howarth; Peter Leedman; Markus Schlaich; Patrick Candy; Vance Matthews
Journal:  BMC Cancer       Date:  2016-02-24       Impact factor: 4.430

10.  MicroRNA-27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling.

Authors:  Rei Matsuyama; Daisuke Okuzaki; Masato Okada; Chitose Oneyama
Journal:  Cancer Sci       Date:  2015-11-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.